{"database": "lobbying", "table": "lobbying_activities", "rows": [[1727959, "b08d56e0-573a-40a3-b488-d5576248fd01", "3A", "GRAY GLOBAL ADVISORS, LLC", 295053, "PRESENCE HEALTH SYSTEM", 2015, "third_quarter", "MMM", "Medicare reimbursement rates for hospitals; Medicare 340B Drug Pricing Program; Medicare Access and Chip Reauthorization Act of 2015; Medicare GME/IME Reform; Medicare disproportionate share payments", "HOUSE OF REPRESENTATIVES,SENATE", 12000, null, 0, 0, "2015-10-09T15:31:35.963000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1727959"], "units": {}, "query_ms": 18.26157496543601, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}